Allergy Therapeutics (AGY) Stock Chart & Stock Price History GBX 8.30 +0.30 (+3.75%) As of 07/18/2025 11:58 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Allergy Therapeutics Stock Price Performance The Allergy Therapeutics (AGY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 48.21%, with a year-to-date return of 27.20%. In the past month, the stock has increased 18.57%, reflecting recent market activity. As of the latest close, Allergy Therapeutics traded at GBX 8.30 with a market cap of £407.95 million and volume of 186,651 shares. Five years ago, the stock traded at GBX 15.20, representing a 45.39% decrease over that period. At the time, it had a market cap of £96.87 million and a volume of 161,145 shares. Receive AGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.75%1 Month Performance+18.57%3 Month Performance+43.10%Year-To-Date Performance+27.20%1 Year Performance+48.21%5 Year Performance-45.39% AGY Stock Chart for Saturday, July, 19, 2025 AGY Chart by TradingView Allergy Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025GBX 8GBX 8.30+3.75%GBX 8.30GBX 7.50186,651 shs£407.95 million07/17/2025GBX 8.25GBX 8-3.03%GBX 8.25GBX 7.70238,837 shs£393.21 million07/16/2025GBX 8GBX 8.25+3.13%GBX 8.30GBX 7.8888,429 shs£405.49 million07/15/2025GBX 8GBX 8GBX 8.20GBX 7.50282,513 shs£393.21 million07/14/2025GBX 8.25GBX 8-3.03%GBX 8.30GBX 7.60575,978 shs£393.21 million07/11/2025GBX 8.25GBX 8.25GBX 8.30GBX 7.86417,367 shs£405.49 million07/10/2025GBX 8GBX 8.25+3.13%GBX 8.25GBX 7.50179,228 shs£405.49 million07/09/2025GBX 8.10GBX 8-1.23%GBX 8.10GBX 7.50201,344 shs£393.21 million07/08/2025GBX 8GBX 8.10+1.25%GBX 8.10GBX 7.48260,751 shs£398.12 million07/07/2025GBX 8GBX 8GBX 8GBX 7.46306,831 shs£393.21 million Get the Latest News and Ratings for AGY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025GBX 8GBX 8GBX 8GBX 7.2575,178 shs£393.21 million07/03/2025GBX 8GBX 8GBX 8GBX 7.2575,178 shs£393.21 million07/02/2025GBX 8GBX 8GBX 8GBX 7.39150,467 shs£393.21 million07/01/2025GBX 7.95GBX 8+0.63%GBX 8GBX 7.25584,082 shs£393.21 million06/30/2025GBX 7.30GBX 7.95+8.90%GBX 7.95GBX 7.161.04 million shs£390.75 million06/27/2025GBX 7.30GBX 7.30GBX 7.50GBX 7.061.21 million shs£358.80 million06/26/2025GBX 7.70GBX 7.30-5.19%GBX 7.85GBX 7.031.50 million shs£358.80 million06/25/2025GBX 6.77GBX 7.70+13.79%GBX 7.70GBX 6.79386,719 shs£378.46 million06/24/2025GBX 7GBX 6.77-3.33%GBX 7.50GBX 6.501.13 million shs£332.60 million06/23/2025GBX 6.90GBX 7+1.45%GBX 7.50GBX 6.50297,610 shs£344.06 million06/20/2025GBX 6.90GBX 6.90GBX 7.35GBX 6.68294,361 shs£339.14 million06/19/2025GBX 7GBX 6.90-1.43%GBX 7.50GBX 6.68123,576 shs£339.14 million06/18/2025GBX 7.10GBX 7-1.41%GBX 7.14GBX 6.75761,218 shs£344.06 million Related Companies APH Stock Chart ANCR Stock Chart VLG Stock Chart EAH Stock Chart STX Stock Chart PXS Stock Chart CEL Stock Chart N4P Stock Chart HELD Stock Chart HLN Stock Chart Receive AGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AGY) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergy Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
